The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART

Objective:To determine the impact of depressive symptoms on mortality among HIV/AIDS patients first initiating HAART and the potential role of patient adherence as a confounder and effect modifier in this association. Methods:The study comprised HIV-positive individuals who were first prescribed HAART between August 1996 and June 2002. Depressive symptoms were assessed using the Center for Epidemiologic Studies Depression Scale. Cox proportional hazards models were used to determine the association between depressive symptoms, adherence and all-cause mortality while controlling for several baseline confounding factors. Results:A total of 563 participants met the study inclusion criteria. Of these subjects, 51% had depressive symptoms at baseline and 23% of participants were less than 95% adherent in the first year of follow-up. The overall all-cause mortality rate was 10%. Multivariate analysis showed that individuals with depressive symptoms and adherence < 95% were 5.90 times (95% confidence interval, 2.55–13.68) more likely to die than adherent patients with no depressive symptoms. The estimated median model-based survival probabilities stratified by adherence and depressive symptoms levels ranged from 81% (interquartile range, 72–89%) for depressive symptoms and adherence < 95% to 97% (interquartile range, 94–98%) for no depressive symptoms and adherence ≥ 95%. Conclusion:The results indicate that both depressive symptoms and adherence were associated with shorter survival among individuals with HIV accessing HAART. Given the high prevalence of depressive symptoms in HIV-positive patients and a strong association with adherence, the findings support improvement in the diagnosis and treatment of depression as well as adherence in order to maximize the effectiveness of HAART.

[1]  David W. Hosmer,et al.  Applied Survival Analysis: Regression Modeling of Time-to-Event Data , 2008 .

[2]  W. Hauck,et al.  Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users , 2003, Journal of General Internal Medicine.

[3]  A. Kilbourne,et al.  Clinical importance of HIV and depressive symptoms among veterans with HIV infection , 2002, Journal of General Internal Medicine.

[4]  Seth C. Kalichman,et al.  Adherence to combination antiretroviral therapies in HIV patients of low health literacy , 1999, Journal of General Internal Medicine.

[5]  B. Rewari,et al.  Antiretroviral Therapy for HIV Infection , 2007 .

[6]  Ross T Tsuyuki,et al.  A meta-analysis of the association between adherence to drug therapy and mortality , 2006, BMJ : British Medical Journal.

[7]  J. Kopec,et al.  Quantifying the effect of health status on health care utilization using a preference-based health measure. , 2005, Social science & medicine.

[8]  D. Stoff,et al.  Workshop report: the effects of psychological variables on the progression of HIV-1 disease , 2004, Brain, Behavior, and Immunity.

[9]  C. Lyketsos,et al.  Depressive symptoms over the course of HIV infection before AIDS , 1996, Social Psychiatry and Psychiatric Epidemiology.

[10]  B. Yip,et al.  Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[11]  J. Becker,et al.  Psychosocial Risk Factors of HIV Morbidity and Mortality: Findings from the Multicenter AIDS Cohort Study (MACS) , 2003, Journal of clinical and experimental neuropsychology.

[12]  J. Leserman.  HIV disease progression: depression, stress, and possible mechanisms , 2003, Biological Psychiatry.

[13]  J. Moskowitz,et al.  Positive Affect Predicts Lower Risk of AIDS Mortality , 2003, Psychosomatic medicine.

[14]  Evan Wood,et al.  Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996 , 2002, AIDS.

[15]  T. Ten Have,et al.  Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. , 2002, The American journal of psychiatry.

[16]  H. Gu,et al.  Progression to AIDS, a clinical AIDS condition and mortality: psychosocial and physiological predictors , 2002, Psychological Medicine.

[17]  B. Yip,et al.  Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up , 2002, AIDS.

[18]  D. Vlahov,et al.  Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. , 2001, JAMA.

[19]  S. Kalichman,et al.  Distinguishing between overlapping somatic symptoms of depression and HIV disease in people living with HIV-AIDS. , 2000, The Journal of nervous and mental disease.

[20]  H. Gu,et al.  Impact of stressful life events, depression, social support, coping, and cortisol on progression to AIDS. , 2000, The American journal of psychiatry.

[21]  M. Dimatteo,et al.  Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. , 2000, Archives of internal medicine.

[22]  Susan Swindells,et al.  Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection , 2000, Annals of Internal Medicine.

[23]  Julio S. G. Montaner,et al.  Depressive Symptoms Decline Among Persons on HIV Protease Inhibitors , 2000, Journal of acquired immune deficiency syndromes.

[24]  R. Hogg,et al.  Adherence to triple therapy and viral load response. , 2000, Journal of acquired immune deficiency syndromes.

[25]  M A Fischl,et al.  Antiretroviral Therapy in Adults Updated Recommendations of the International AIDS Society–USA Panel , 2000 .

[26]  V. Soriano,et al.  Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. , 1999, AIDS.

[27]  D. Perkins,et al.  Progression to AIDS: the effects of stress, depressive symptoms, and social support. , 1999, Psychosomatic medicine.

[28]  S. Hammer,et al.  Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. , 1998, JAMA.

[29]  D. Perkins,et al.  Severe stress, depressive symptoms, and changes in lymphocyte subsets in human immunodeficiency virus-infected men. A 2-year follow-up study. , 1997, Archives of general psychiatry.

[30]  E. Vittinghoff,et al.  Depressive affect and survival among gay and bisexual men infected with HIV. , 1996, Archives of internal medicine.

[31]  W Winkelstein,et al.  Comorbidity and survival in HIV-infected men in the San Francisco Men's Health Survey. , 1996, Annals of epidemiology.

[32]  Douglas D. Richman,et al.  Antiretroviral therapy for HIV infection in 1996 : Recommendations of an international panel , 1996 .

[33]  S. Hammer,et al.  Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA. , 1996, JAMA.

[34]  Shirley J. Semple,et al.  Relationship of psychosocial factors to HIV disease progression , 1996, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[35]  C. Mulrow,et al.  Case-Finding Instruments for Depression in Primary Care Settings , 1995, Annals of Internal Medicine.

[36]  Julio S. G. Montaner,et al.  Lower socioeconomic status and shorter survival following HIV infection , 1994, The Lancet.

[37]  D L Patrick,et al.  Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). , 1994, American journal of preventive medicine.

[38]  R. Hogg,et al.  Higher socioeconomic status is associated with slower progression of HIV infection independent of access to health care. , 1994, Journal of clinical epidemiology.

[39]  M. Chesney,et al.  Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. , 1993, JAMA.

[40]  S. Greenland,et al.  Simulation study of confounder-selection strategies. , 1993, American journal of epidemiology.

[41]  G. Barnes,et al.  Symptoms of Depression in a Canadian Urban Sample * , 1988, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[42]  L. Radloff.  The CES-D Scale , 1977 .

[43]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.